|
English
|
正體中文
|
简体中文
|
2814562
|
|
???header.visitor??? :
27298283
???header.onlineuser??? :
1524
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"roy ac"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國家衛生研究院 |
2020-04 |
Management of early stage gastro-oesophageal cancers: Expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty
|
Roy, AC;Shapiro, J;Burge, M;Karapetis, CS;Pavlakis, N;Segelov, E;Chau, I;Lordick, F;Chen, LT;Barbour, A;Tebbutt, N;Price, T |
| 國家衛生研究院 |
2013-06-21 |
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
|
Roy, AC;Park, SR;Cunningham, D;Kang, YK;Chao, Y;Chen, LT;Rees, C;Lim, HY;Tabernero, J;Ramos, FJ;Kujundzic, M;Cardic, MB;Yeh, CG;De Gramont, A |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
